| Trial ID: | L3632 |
| Source ID: | NCT01467414
|
| Associated Drug: |
Insulin Degludec
|
| Title: |
A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin degludec
|
| Outcome Measures: |
Primary: Area under the glucose infusion rate curve during one dosing interval at steady state, Within 0-24 hours after last dosing | Secondary: Maximum glucose infusion rate at steady state, Within 0-24 hours after last dosing|Area under the serum insulin degludec concentration-time curve during one dosing interval at steady state, Within 0-24 hours after last dosing|Maximum observed serum insulin degludec concentration at steady state, Within 0-24 hours after last dosing
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
1
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-10
|
| Completion Date: |
2011-12
|
| Results First Posted: |
|
| Last Update Posted: |
2013-11-27
|
| Locations: |
Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01467414
|
